April 19, 2012
by admin
0 comments
DrugBaron has been concerned about the damage that failures in the system of publishing academic research is doing to the global pharmaceutical industry (and to much else besides) long before it became fashionable. In the six months since ’Rotten Foundations‘ … Continue reading
April 18, 2012
by admin
2 Comments
The efficiency of pharmaceutical R&D is declining. That much is not in doubt: record R&D expenditure in the last decade has led to fewer drug approvals overall, and almost a complete drought in genuine, first-in-class innovation. Set aside biologicals, and … Continue reading
April 9, 2012
by admin
0 comments
Confirming the launch of the Patent Box tax break for innovative technologies from April 2013, the UK government has made one of the most far reaching changes to corporate tax structure in recent times. The full implications of the new … Continue reading